Suppr超能文献

中国绝经前和绝经后乳腺癌女性术后局部区域放疗的临床结局

Clinical outcomes of post-operative locoregional radiotherapy in pre-menopausal and post-menopausal Chinese women with breast cancer.

作者信息

Mok T S, Kwan W H, Yeo W M, Chan A T, Chan E C, Chak K, Chow D L, Lo C, Leung T W, Teo P M

机构信息

Department Of Clinical Oncology, The Chinese University Of Hong Kong, Prince Of Wales Hospital, Shatin, New Territories, Hong Kong.

出版信息

Radiother Oncol. 2000 Mar;54(3):201-8. doi: 10.1016/s0167-8140(99)00176-0.

Abstract

BACKGROUND AND PURPOSES

Recent randomized studies from the West show that post-operative locoregional radiotherapy improves survival in lymph node (LN) positive pre-menopausal women with breast cancer but this benefit has not been established in the Chinese population. There is no published study on clinical outcomes (locoregional recurrence, survival and toxicities) of post-operative locoregional radiotherapy in Chinese women with breast cancer.

MATERIALS AND METHODS

We conducted a retrospective study of 399 female Chinese patients with breast cancer who had received post-mastectomy locoregional radiotherapy in our center between 1984 and 1990. The patients were stratified according to tumor size, menopausal and LN status. We analyzed the incidence and pattern of locoregional recurrence, distant recurrence, survival rates and toxicity related to radiotherapy.

RESULTS

Of the 399 patients 216 were pre-menopausal and 183 were post-menopausal. The mean age was 49.3 years (23-83). Distribution of tumor size and LN status of the two groups was similar. Median follow-up was 71.9 months. Locoregional recurrence occurred in 57 (14.3%) patients (pre-menopausal 24 (11.1%); post-menopausal 33 (18.3%) P=0.489). Recurrence was more common in LN positive patients (18.2%) than LN negative patients (9.2%). The pattern of locoregional recurrence was: chest wall 24, axilla LN 12, supraclavicular LN 10, chest plus LN 11. The distant recurrence rate was 39.6% for all patients and 75.4% for patients with locoregional recurrences. The overall 10-year survival rate for all patients was 54%. For LN positive patients the 10-year survival rate of pre-menopausal and post-menopausal women was 38 and 51%, respectively (P=0.207), and for LN negative patients the rate was 73 and 70%, respectively (P=0.603). Acute skin toxicity included redness (30.8%), dry desquamation (12.8%), and wet desquamation (6. 8%). Long-term toxicities included skin atrophy (0.3%), telangectasia (3.3%), pneumonitis (2.8%) and brachial plexus palsy (1.3%).

CONCLUSIONS

In our series Chinese patients with node-positive breast cancer have a relatively high locoregional recurrence rate in spite of mastectomy and post-operative radiotherapy. Limited use of adjuvant system chemotherapy may account, at least in part, for this finding. Clinical outcomes of post-operative radiotherapy in pre-menopausal and post-menopausal breast cancer patients are similar.

摘要

背景与目的

西方近期的随机研究表明,术后局部区域放疗可提高绝经前淋巴结(LN)阳性乳腺癌女性的生存率,但这一益处尚未在中国人群中得到证实。目前尚无关于中国乳腺癌女性术后局部区域放疗临床结局(局部区域复发、生存率和毒性)的发表研究。

材料与方法

我们对1984年至1990年间在本中心接受乳房切除术后局部区域放疗的399例中国女性乳腺癌患者进行了回顾性研究。患者根据肿瘤大小、绝经状态和LN状态进行分层。我们分析了局部区域复发、远处复发的发生率和模式、生存率以及放疗相关毒性。

结果

399例患者中,216例为绝经前患者,183例为绝经后患者。平均年龄为49.3岁(23 - 83岁)。两组患者的肿瘤大小和LN状态分布相似。中位随访时间为71.9个月。57例(14.3%)患者发生局部区域复发(绝经前24例(11.1%);绝经后33例(18.3%),P = 0.489)。LN阳性患者的复发(18.2%)比LN阴性患者(9.2%)更常见。局部区域复发模式为:胸壁24例,腋窝LN 12例,锁骨上LN 10例,胸部加LN 11例。所有患者的远处复发率为39.6%,局部区域复发患者的远处复发率为75.4%。所有患者的10年总生存率为54%。LN阳性患者中,绝经前和绝经后女性的10年生存率分别为38%和51%(P = 0.207),LN阴性患者的生存率分别为73%和70%(P = 0.603)。急性皮肤毒性包括发红(30.8%)、干性脱皮(12.8%)和湿性脱皮(6.8%)。长期毒性包括皮肤萎缩(0.3%)、毛细血管扩张(3.3%)、肺炎(2.8%)和臂丛神经麻痹(1.3%)。

结论

在我们的系列研究中,尽管进行了乳房切除术和术后放疗,但中国淋巴结阳性乳腺癌患者的局部区域复发率相对较高。辅助系统化疗的使用有限可能至少部分解释了这一发现。绝经前和绝经后乳腺癌患者术后放疗的临床结局相似。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验